What we do Pharmaids Pharmaceuticals Limited is an Indian pharmaceutical company engaged in contract research and manufacturing services in specialty chemicals and generic products for orthopedic, neuro, and gastro segments. |
Founded in 1,989 |
Market share A growing player in pharma CRAMS with increased consolidated revenue of Rs. 19.55 crore in FY25, expanding through acquisitions and diversification. |
Problem solved Provides quality pharmaceutical ingredients and contract manufacturing solutions, addressing needs in specialty and generic drug development. |
Top clients or who we serve Serves pharmaceutical companies via B2B contract manufacturing and research services in healthcare-related verticals. |
Key management - |
Our journey and innovations Founded in 1989, expanded via 2019 merger with Emergent Bio Naturals and acquisitions of subsidiaries and partnership stakes up to 2025. |
Where we operate Primarily operates in India with subsidiaries in Karnataka and Telangana regions. |
Top products or what we offer Specialty chemicals, skincare, hospital care products, and contract research and manufacturing services in pharmaceutical segments. |
Top brands - |
Raw materials needed Chemical compounds for specialty and generic pharmaceuticals. |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue from contract research and manufacturing is largely recurring based on client projects and supply agreements. |
Our industry position Emerging mid-sized firm in Indian CRAMS sector, leveraging acquisitions and expanding footprint. |
Financial highlights Consolidated revenue Rs. 19.55 crore; net loss Rs. 10.78 crore in FY25; growing revenue base with operational investments underway. |
Geographical revenue split Revenue primarily from domestic Indian market. |
Order book - |
Whats driving growth Strategic acquisitions, expanded subsidiaries, and new business extensions drive revenue growth and diversify portfolio. |
Our future plans Plans include monetization of land assets, expanding R&D, and growing manufacturing capabilities via subsidiaries. |
Our green promise Committed to sustainable operations with awareness on energy conservation; exploring alternate energy options. |
Our people and values Emphasizes ethical conduct, workplace safety, diversity, and a harassment-free environment. |
Key challenges ahead Financial prudence needed due to operational losses; delays in project execution impacting growth timing. |
Interesting facts Amalgamated Emergent Bio Naturals in 2019; recent series of acquisitions increased group presence and capabilities. |
Risks and strategy Mitigates operational risks through strategic partnerships and asset monetization to maintain liquidity and growth potential. |
